14th Annual RNA Therapeutics Conference

SAE Media Group invites you to join the 14th Annual RNA Therapeutics Conference, taking place on 8 and 9 February 2023, in London, UK.

Building on the success of previous years, the RNA Therapeutics Conference will bring together industry experts from leading pharma and biotech companies to provide an expert and holistic view on the latest developments of the industry.

RNA therapeutics is a rapidly expanding industry with increasingly growing potential for immunotherapy, personalised medicines, and treatment of genetic, infectious and chronic diseases. This is reflected with the value of the global antisense & RNA therapeutics market expected to reach USD 1.81 billion by 2025, growing at a CAGR of 7.5%.

With Covid-19 rapidly accelerating the RNA landscape through massive regulatory successes, the recent advent of CRISPR, an RNA-guided gene-editing technology, as well as new strides in the delivery of messenger RNA transcribed in vitro, there has been considerable progress in the development of RNA medicines and a major expansion of the RNA-therapeutics field.

This year’s conference will reflect on how the industry has adapted and played a pivotal role in global health over the past year and will discuss the takeaways for future mRNA therapeutic development.

Benefits of attending:

• Explore how mRNA leads the way in the genetic medicine space as the next generation of novel drug modalities
• Investigate the latest trends in AI drug discovery as a tool for designing novel RNA based therapeutics
• Enhance your knowledge of the latest innovations in RNA application and RNA delivery techniques with case studies from BioNTech, Neuway Pharma and Ethris GmbH
• Engage in the growing advances and development of novel RNA molecules in the treatment of chronic respiratory, neurodegenerative, and infectious diseases

Who should attend:

• Directors of novel RNA therapies
• CEOs
• Senior and expert scientists
• Chief Medical Officers
• Chief Technical Officers
• Senior Vice Presidents
• Global Heads of mRNA R&D
• Global Medical Directors
• Heads of Translational Medicine
• Director, Clinical Pharmacology
• Global Head of RNA and Targeted Therapeutics
• Clinical Science Director
• Head of Biology
• Director, Genetic Medicine
• Associate Director

EARLY-BIRD RATES:

• REGISTER BY 31ST OCTOBER AND SAVE £400
• REGISTER BY 3OTH NOVEMBER AND SAVE £200
• REGISTER BY 16TH DECEMBER AND SAVE £100